Kuwano H, Sumiyoshi K, Nozoe T, Yasuda M, Watanabe M, Sugimachi K
Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Eur J Surg Oncol. 1995 Aug;21(4):368-73. doi: 10.1016/s0748-7983(95)92384-5.
We examined the DNA pattern, AgNOR number and PCNA-positive ratio (PCNA ratio) from biopsy specimens of oesophageal carcinoma, and attempted to identify any prognostic factors for oesophageal carcinoma. DNA analysis: the cell nuclear DNA content was measured and the distribution pattern of the DNA content was grouped into four types according to the ploidy pattern (n = 182). The survival rate of patients with high-ploidy tumours (type III and IV) was shorter than that for low-ploidy tumours (type II), (P < 0.05). AgNOR number (n = 99) and PCNA ratio (n = 41): the AgNOR number and PCNA ratio were measured from 100 cancer cells in each specimen. Both the high-AgNOR-number patients (> or = 5) and the high-PCNA-ratio patients (> or = 35) demonstrated poorer prognoses than the low-rate patients (P < 0.05). These results suggest that the DNA pattern, AgNOR number and PCNA ratio may thus reflect the proliferative activity of tumours and therefore also offer the possibility of interdependence among these three factors.
我们检测了食管癌活检标本的DNA模式、核仁组成区嗜银蛋白(AgNOR)数量及增殖细胞核抗原阳性率(PCNA比率),并试图确定食管癌的任何预后因素。DNA分析:测量细胞核DNA含量,并根据倍体模式将DNA含量的分布模式分为四种类型(n = 182)。高倍体肿瘤(III型和IV型)患者的生存率低于低倍体肿瘤(II型)患者(P < 0.05)。AgNOR数量(n = 99)和PCNA比率(n = 41):在每个标本中从100个癌细胞测量AgNOR数量和PCNA比率。高AgNOR数量患者(≥5)和高PCNA比率患者(≥35)的预后均比低比率患者差(P < 0.05)。这些结果表明,DNA模式、AgNOR数量和PCNA比率可能因此反映肿瘤的增殖活性,因此这三个因素之间也可能存在相互依存关系。